Document Detail

The future of neuro-oncology.
MedLine Citation:
PMID:  7766373     Owner:  NLM     Status:  MEDLINE    
Treatment options for patients with malignant primary and metastatic lesions to the brain are limited and offer little therapeutic benefit. Despite the use of conventional therapy survival of patients is measured in weeks and months. The use of gene therapy with ganciclovir administration and immunotherapy using targeted protein toxins are two experimental approaches to improving this poor prognosis through regional therapy.
H L DeVroom
Related Documents :
24931113 - Extended high cut-off haemodialysis for myeloma cast nephropathy in auckland, 2008-2012.
21882203 - Swallowing function after transoral laser microsurgery (tlm) ± adjuvant therapy for ad...
2827883 - Sequential combination chemotherapy for malignant germ cell tumors of the ovary.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care nursing clinics of North America     Volume:  7     ISSN:  0899-5885     ISO Abbreviation:  Crit Care Nurs Clin North Am     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-07-06     Completed Date:  1995-07-06     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8912620     Medline TA:  Crit Care Nurs Clin North Am     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  179-83     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Neoplasms / therapy*
Medical Oncology / methods*,  trends
Neurology / methods*,  trends

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neurologic involvement of systemic cancer.
Next Document:  Evaluation of the advanced practice nurse role in acute and specialty care.